Neuropeptides and their receptors: Innovative science providing novel therapeutic targets

British Journal of Pharmacology

Volumn 147, Issue SUPPL. 1, 2006, Pages

  Brain, Susan D ^a   Cox, Helen M ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Calcitonin gene related peptide; Neurokinins; Neuropeptide Y; Neuropeptides; Receptor mechanisms

Indexed keywords

1 NAPHTHALENESULFONIC ACID [4 [(4 AMINO 2 QUINAZOLINYLAMINO)METHYL] CYCLOHEXYLMETHYL]AMIDE; 1 NAPHTHALENESULFONIC ACID [4 [(4 AMINO 2 QUINAZOLINYLAMINO)METHYL]CYCLOHEXYLMETHYL]AMIDE; ADRENOMEDULLIN; ALPHA CALCITONIN GENE RELATED PEPTIDE; AMYLIN; BETA CALCITONIN GENE RELATED PEPTIDE; CALCITONIN GENE RELATED PEPTIDE[8-37]; GR 231118; INTERMEDIN; KININ DERIVATIVE; L 150 804; L 152 804; N [2 [1,2 DIHYDRO 3,5(4H) DIOXO 1,2 DIPHENYL 1,2,4 TRIAZOL 4 YL]ETHYL] N2 [[1 [2 [4 [5,11 DIHYDRO 6(6H) OXODIBENZ[B,E]AZEPIN 11 YL] 1 PIPERAZINYL] 2 OXOETHYL]CYCLOPENTYL]ACETYL]ARGININAMIDE; N2 DIPHENYLACETYL N (4 UREIDOMETHYLBENZYL)ARGININAMIDE; NALPHA (DIPHENYLACETYL) N (4 HYDROXYBENZYL) DEXTRO ARGININAMIDE; NEUROKININ 1 RECEPTOR ANTAGONIST; NEUROKININ A; NEUROKININ B; NEUROPEPTIDE; NEUROPEPTIDE FF; NEUROPEPTIDE Y; PANCREAS POLYPEPTIDE; PEPTIDE YY; SB 273779; SUBSTANCE P; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTHRITIS; ASTHMA; BLOOD VESSEL PERMEABILITY; CLINICAL TRIAL; ENTERITIS; HUMAN; NONHUMAN; PATHOLOGY; PHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SCIENCE; SENSORY NERVE; UPREGULATION;

ANIMALS; ANTI-ANXIETY AGENTS; ANTI-OBESITY AGENTS; CALCITONIN GENE-RELATED PEPTIDE; HUMANS; NEUROPEPTIDE Y; NEUROPEPTIDES; PEPTIDE YY; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, NEUROPEPTIDE; RECEPTORS, SENSORY; SENSORY RECEPTOR CELLS; SUBSTANCE P; VASODILATOR AGENTS;

EID: 30444455299     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706461     Document Type: Review

References (60)

1. AIYAR, N., DAINES, R.A., DISA, J., CHAMBERS, P.A., SAUERMELCH, C.F., QUINIOU, M., KHANDOUDI, N., GOUT, B., DOUGLAS, S.A. & WILLETTE, R.N. (2001). Pharmacology of SB-273779, a nonpeptide calcitonin gene-related peptide 1 receptor antagonist. J. Pharmacol. Exp. Ther., 296, 768-775.
2. BARABAN, S.C., HOLLOPETER, G., SCHWARTZKROIN, P.A. & PALMITER, R.D. (1997). Knock-out mice reveal a critical anti-epileptic role for neuropeptide Y. J. Neurosci., 17, 8927-8936.
3. BEVAN, S., HOTHI, S., HUGHES, G., JAMES, I.F., RANG, H.P., SHAH, K., WALPOLE, C.S. & YEATS, J.C. (1992). Capsazepine: a competitive antagonist of the sensory neurone excitant capsaicin. Br. J. Pharmacol., 107, 544-552.
4. BEWICK, G.A., GARDINER, J.V., DHILLO, W.S., WHITE, N.E., WEBSTER, Z., GHATEI, M.A. & BLOOM, S.R. (2005). Post-embryonic ablation of AgRP neurons in mice leads to a lean, hypophagic phenotype. FASEB J., 19, 1680-1682.
5. BLOCK, M.H., BOYER, S., BRAILSFORD, W., BRITTAIN, D.R., CARROLL, D., CHAPMAN, S., CLARKE, D.S., DONALD, C.S., FOOTE, K.M., GODFREY, L., LADNER, A., MARSHAM, P.R., MASTERS, D.J., MEE, C.D., O'DONOVAN, M.R., PEASE, J.E., PICKUP, A.G., RAYNER, J.W., ROBERTS, A., SCHOFIELD, P., SULEMAN, A. & TURNBULL, A.V. (2002). Discovery and optimization of a series of carbazole ureas as NPY5 antagonists for the treatment of obesity. J. Med. Chem., 45, 3509-3523.
6. BRAIN, S.D. & GRANT, A.D. (2004). Vascular actions of calcitonin gene-related peptide and adrenomedullin. Physiol. Rev., 84, 903-934.
7. BRAIN, S.D., WILLIAMS, T.J., TIPPINS, J.R., MORRIS, H.R. & MACINTYRE, I. (1985). Calcitonin gene-related peptide is a potent vasodilator. Nature, 313, 54-56.
8. BURNSTOCK, G. (1976). Do some nerve cells release more than one transmitter? J. Neurosci., 1, 239-248.
9. CATERINA, M.J., SCHUMACHER, M.A., TOMINAGA, M., ROSEN, T.A., LEVINE, J.D. & JULIUS, D. (1997). The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature, 389, 816-824.
10. 1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting. Cancer, 97, 2290-2300.
11. COTTRELL, G.S., ROOSTERMAN, D., MARVIZON, J.C., SONG, B., WICK, E., PIKIOS, S., WONG, H., BERTHELIER, C., TANG, Y., STERNINI, C., BUNNETT, N.W. & GRADY, E.F. (2005). Localization of calcitonin receptor-like receptor and receptor activity modifying protein 1 in enteric neurons, dorsal root ganglia, and the spinal cord of the rat. J. Comp. Neurol., 490, 239-255.
12. DONG, Y.L., GREEN, K.E., VEGIRAGU, S., HANKINS, G.D., MARTIN, E., CHAUHAN, M., THOTA, C. & YALLAMPALLI, C. (2005). Evidence for decreased calcitonin gene-related peptide (CGRP) receptors and compromised responsiveness to CGRP of feto-placental vessels in preeclamptic pregnancies. J. Clin. Endocrinol. Metab., 90, 2336-2343.
13. DOODS, H., GAIDA, W., WIELAND, H.A., DOLLINGER, H., SCHNORRENBERG, G., ESSER, F., ENGEL, W., EBERLEIN, W. & RUDOLF, K. (1999). BIIE0246: a selective and high affinity neuropeptide Y Y(2) receptor antagonist. Eur. J. Pharmacol., 384, R3-R5.
14. DOODS, H., HALLERMAYER, G., WU, D., ENTZEROTH, M., RUDOLF, K., ENGEL, W. & EBERLEIN, W. (2000). Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist. Br. J. Pharmacol., 129, 420-423.
15. DUMONT, Y., MOYSE, E., FOURNIER, A. & QUIRION, R. (2005). Evidence for the existence of an additional class of neuropeptide Y receptors in the rat brain. J. Pharmacol. Exp. Therap., 315, 99-108.
16. EDVINSSON, L., HÅKANSON, R., WAHLESTEDT, C. & UDDMAN, R. (1987). Effects of neuropeptide Y on the cardiovascular system. Trends Pharmacol. Sci., 8, 231-235.
17. 5 receptors. Eur. J. Neurosci., 22, 1417-1430.
18. ERICKSON, J.C., CLEGG, K.E. & PALMITER, R.D. (1996). Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature, 381, 415-418.
19. FOREMAN, J.C., JORDAN, C.C., OEHME, P. & RENNER, H. (1983). Structure-activity relationships for some substance P-related peptides that cause wheal and flare reactions in human skin. J. Physiol., 335, 449-465.
20. 1 receptor agonist, Proc. Natl. Acad. Sci. U.S.A. 87, 182-186.
21. HAY, D.L., CONNER, A.C., HOWITT, S.G., SMITH, D.M. & POYNER, D.R. (2004). The pharmacology of adrenomedullin receptors and their relationship to CGRP receptors. J. Mol. Neurosci., 22, 105-113.
22. HOLZER, P. (1998). Neurogenic vasodilatation and plasma leakage in the skin. Gen. Pharmacol., 30, 5-11.
23. HOLLIDAY, N.D., MICHEL, M.C. & COX, H.M. (2004). NPY receptor subtypes and their signal transduction. In: Neuropeptide Y and Related Peptides, Handbook of Experimental Pharmacology, ed. Michel M.C. Vol. 162, pp 45-74. Berlin: Springer-Verlag.
24. HORVATH, T.L. (2005). The hardship of obesity: a soft-wired hypothalamus. Nature Neurosci., 8, 561-565.
25. HYLAND, N.P. & COX, H.M. (2004). NPY-like peptides, Y receptors and gastrointestinal function. In: Neuropeptide Y and Related Peptides, Handbook of Experimental Pharmacology, ed. Michel M.C. Vol. 162, pp. 389-408. Berlin: Springer-Verlag.
26. 2 antagonism in mouse and human colonic tissues. Br. J. Pharmacol., 139, 863-871.
27. JANCSó, G., KIRALY, E. & JANSCó-GABOR, A. (1977). Pharmacologically induced selective degeneration of chemosensitive primary sensory neurones. Nature, 270, 741-743.
28. KEEBLE, J.E. & BRAIN, S.D. (2004). A role for substance P in arthritis? Neurosci. Lett., 361, 176-179.
29. 1) receptor antagonist in major depression. Neuropsychopharmacology, 29, 385-392.
30. LARHAMMAR, D., FREDRIKSSON, R., LARSON, E.T. & SALANECK, E. (2004). Phylogeny of NPY-family peptides and their receptors. In: Neuropeptide Y and Related Peptides, Handbook of Experimental Pharmacology, ed. Michel M.C. Vol. 162, pp 76-100. Berlin: Springer-Verlag.
31. LEMBECK, F. (1953). Central transmission of afferent impulses. III. Incidence and significance of the substance P in the dorsal roots of the spinal cord. Naunyn Schmiedebergs Arch. Exp. Pathol. Pharmakol., 219, 197-213.
32. LE ROUX, C.W., BATTERHAM, R.L., AYLWIN, S.J.B., PATTERSON, M., BORG, C.M., WYNNE, K.J., KENT, A., VINCENT, R.P., GHATEI, M.A. & BLOOM, S.R. (2005). Attenuated peptide YY release in obese subjects is associated with reduced satiety. Endocrinology (in press).
33. LEWIS, T. (ed). (1927). Released substances the cause of the triple response. In: The Blood Vessels of the Human Skin and their Responses. London: Shaw and Son.
34. LUNDBERG, J.M. (1996). Pharmacology of cotransmission in the autonomic nervous system: integrative aspects on amines, neuropeptides, ATP, amino acids and nitric oxide. Pharmacol. Rev., 48, 113-178.
35. MAGGI, C.A. (1991). The pharmacology of the efferent function of sensory nerves. J. Auton. Pharmacol., 11, 173-208.
36. MAGGI, C.A. (1995). The mammalian tachykinin receptors. Gen. Pharmacol., 26, 911-944.
37. MCGOWAN, B.M.C. & BLOOM, S.R. (2004). Peptide YY and appetite control. Curr. Opin. Pharmacol., 4, 583-588.
38. MCLATCHIE, L.M., FRASER, N.J., MAIN, M.J., WISE, A., BROWN, J., THOMPSON, N., SOLARI, R., LEE, M.G. & FOORD, S.M. (1998). RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature, 393, 333-339.
39. MENTLEIN, R., DAHMS, P., GRANDT, D. & KRUGER, R. (1993). Proteolytic processing of neuropeptide Y and peptide YY by dipeptidyl peptidase IV. Reg. Peptides, 49, 133-144.
40. MICHEL, M.C., BECK-SICKINGER, A., COX, H.M., DOODS, H.N., HERZOG, H., LARHAMMAR, D., QUIRION, R., SCHWARTZ, T. & WESTFALL, T. (1998). XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol. Rev., 50, 143-150.
41. 2 suppression of excitation. J. Neurophysiol., 92, 3266-3275.
42. OLESEN, J., DIENER, H.C., HUSSTEDT, I.W., GOADSBY, P.J., HALL, D., MEIER, U., POLLENTIER, S. & LESKO, L.M. (2004). BIBN 4096 BS Clinical Proof of Concept Study Group. Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N. Engl. J. Med., 350, 1104-1110.
43. PAGE, N.M. (2004). Hemokinins and endokinins. Cell Mol. Life Sci., 61, 1652-1663.
44. 1 receptor. Nat. Med., 4, 722-726.
45. PLAYFORD, R.J., DOMIN, J., BEACHAM, J., PARMAR, K.B., TATEMOTO, K., BLOOM, S.R. & CALAM, J. (1990). Preliminary report: role of peptide YY in defence against diarrhoea. Lancet, 335, 1555-1557.
46. ROH, J., CHANG, C.L., BHALLA, A., KLEIN, C. & HSU, S.Y. (2004). Intermedin is a calcitonin/calcitonin gene-related peptide family peptide acting through the calcitonin receptor-like receptor/receptor activity-modifying protein receptor complexes. J. Biol. Chem., 279, 7264-7274.
47. ROSEBERRY, A.G., LUI, H., JACKSON, A.C., CAI, X. & FRIEDMAN, J.M. (2004). Neuropeptide Y-mediated inhibition of proopiomelanocortin neurons in the arcuate nucleus shows enhanced desensitisation in ob/ob mice. Neuron, 41, 711-722.
48. 2 receptors in body weight regulation revealed in conditional knockout mice. Proc. Natl. Acad. Sci. U.S.A., 99, 8938-8943.
49. 4 receptor knockout rescues fertility in ob/ob mice. Genes Dev, 16, 1077-1088.
50. 4) receptor. Peptides, 19, 537-542.
51. SCHONHOFF, S., BAGGIO, L., RATINEAU, C., RAY, S.K., LINDNER, J., MAGNUSON, M.A., DRUCKER, D.J. & LEITER, A.B. (2005). Energy homeostasis and gastrointestinal endocrine differentiation do not require the anorectic hormone peptide YY. Mol. Cell. Biol., 25, 4189-4199.
52. SCHWARTZ, T.W., FUHLENDORFF, J., KJEMS, L.L., KRISTENSEN, M.S., VERVELDE, M., O'HARE, M., KRSTENANSKY, J.K. & BJORNHOLM, B. (1990). Signal epitopes in the three-dimensional structure of neuropeptide Y. Ann. NY Acad. Sci., 611, 35-47.
53. STORER, R.J., AKERMAN, S. & GOADSBY, P.J. (2004). Calcitonin gene-related peptide (CGRP) modulates nociceptive trigeminovascular transmission in the cat. Br. J. Pharmacol., 142, 1171-1181.
54. TATEMOTO, K., CARLQUIST, M. & MUTT, V. (1982). Neuropeptide Y- a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature, 296, 659-660.
55. 2 receptors. Eur J Neurosci., 18, 143-148.
56. THIELE, T.E. & HEILIG, M. (2004). Behavioural effects of neuropeptide Y. In: Neuropeptide Y and Related Peptides, Handbook of Experimental Pharmacology, ed. Michel M.C. Vol. 162, pp. 251-282. Berlin: Springer-Verlag.
57. URBAN, L.A. & FOX, A.J. (2000). NK1 receptor antagonists - are they really without effect in the pain clinic? Trends Pharmacol. Sci., 21, 462-464.
58. VON EULER, U.S. & GADDUM, J.H. (1931). An unidentified depressor substance in certain tissue extracts. J. Physiol., 72, 74-87.
59. 2-receptors. In: Neuronal Messengers in Vascular Function, ed. Nobin, A., Owman, C. & Arneklo-Nobin, B. pp. 231-242. Amsterdam: Elsevier Science Publishers.
60. 1 receptor antagonist BIBO3304 and its effect on feeding in rodents. Br. J. Pharmacol., 125, 549-555.